Streetbeat News

GOCO

GoHealth, Inc.

https://www.gohealth.com

Industry

Insurance - Brokers

GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareInternal; MedicareExternal; Individual and Family Plans (IFP) and OtherInternal; and IFP and OtherExternal. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carriers and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois with additional offices in Charlotte, North Carolina, Lindon, Utah, Bratislava, Slovakia, and Kosice, Slovakia.

Open

12.48

Mkt cap

121M

Volume

26K

High

12.50

P/E Ratio

-3.62

52-wk high

16.44

Low

11.87

Div yield

N/A

52-wk low

7.27

GoHealth reported its Q2 2024 financial results, with a GAAP EPS of $(2.70), missing the estimate of $(2.57). Sales were $105.870 million, falling short of the $141.792 million estimate.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 10:02 am

Shares of insurance companies are trading lower amid overall weakness following concerns for recently issued US economic data.

Portfolio Pulse from Benzinga Newsdesk

August 05, 2024 | 2:49 pm

A House panel is considering a new plan for Medicare to cover Wegovy, a weight-loss drug, and cancer blood tests. This could impact companies like Novo Nordisk (NVO), the maker of Wegovy, and other healthcare providers.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2024 | 6:42 pm

GoHealth, Inc. (NASDAQ:GOCO) has appointed Katherine O'Halloran as interim CFO following the departure of former CFO Jason Schulz. The company will conduct a search for a permanent CFO.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 12:06 pm

GoHealth (NASDAQ:GOCO) reported Q1 2024 adjusted EPS of $(0.85), surpassing the $(0.95) estimate, with sales of $185.6M exceeding the $180.154M forecast, marking a 1.33% year-over-year increase.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 10:09 am

RBC Capital analyst Ben Hendrix maintains a Sector Perform rating on GoHealth (NASDAQ:GOCO) and lowers the price target from $20 to $13.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 3:03 pm

GoHealth's shares dropped following the announcement of worse-than-expected Q4 revenues.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 1:16 pm

GoHealth (NASDAQ:GOCO) reported Q4 GAAP EPS of $(0.22), missing the consensus estimate of $2.73 by 108.06%, and sales of $276.70M, missing the estimate of $363.88M by 23.96%. Despite these misses, the company saw a significant increase over the previous year, with losses improving by 96.86% and sales increasing by 298.84%.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 10:05 am

Numerous companies are scheduled to report their earnings on March 14, 2024, covering a wide range of industries from technology to healthcare. The reports include a mix of expected quarterly earnings and losses, with key figures such as revenue and per-share earnings highlighted for each company.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 9:52 am

GoHealth (NASDAQ:GOCO) is expected to report an EPS of $2.72 in its upcoming quarterly earnings on March 14, 2024. Analysts and investors are keen on whether the company will surpass this estimate and provide positive future guidance. Historically, GoHealth has had mixed earnings performance, with a notable beat last quarter leading to a 3.18% share price increase. However, over the last year, GOCO shares have declined by 25.2%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 5:01 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.